Check out Tulsian's bets in IT & pharma space

SP Tulsian of sptulsian.com told CNBC-TV18, "Two sectors are seen large beneficiary from the dollar-rupee. One is IT sector and second is pharma sector. One should really go for the larger companies in both because I do not think that you have the quality or comfort in both sectors to go in on long position in the midcap stocks. But, yes if somebody still wants to have the midcap stocks in their portfolio because of rupee weakness, one can look for few IT stocks like Hexaware Technologies, Geometric at the current level. But, I would not advise that in case of the pharma. Better look for the larger ones like Dr Reddy's Laboratories, Lupin or maybe the stocks like Sun Pharma. So, these are few good ideas in the IT and pharma space," said SP Tulsian